Buparlisib in Metastatic Transitional Cell Carcinoma of the Urothelium
Clinical trial NCT01551030 · COMPLETED
Trial details
- NCT number
- NCT01551030
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2020-09-02
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.